Skip to content

EBIT at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$116.17M-23.8%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$110.03M-3.2%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.77M-31.2%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's EBIT?
Precigen (PGEN) reported EBIT of -$5.99M in Q1 2026.
How has Precigen's EBIT changed year-over-year?
Precigen's EBIT increased by 73.5% year-over-year, from -$22.6M to -$5.99M.
What is the long-term trend for Precigen's EBIT?
Over 3 years (2021 to 2024), Precigen's EBIT has grown at a 8.4% compound annual growth rate (CAGR), from -$105.96M to -$135.03M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.